top of page
dots_edited.png

FDARC FOR REGULATED STAKEHOLDERS

FDA Regulatory Counsel provides strategic legal and commercial guidance to FDA-regulated consumer products companies and other industry stakeholders. Our knowledge and experience allow us to steward day-to-day compliance, handle complex challenges and strategize commercial and regulatory success.

dots_edited.png

REGULATORY & STRATEGIC COUNSEL

FDARC provides insightful counsel. We believe that deep knowledge of regulatory law is only the starting point. The experience to apply it in tailored ways, and a contextual understanding the quickly-evolving life sciences landscape, is what makes us a value-add partner. Ultimately, understanding real world implications - and seeing around corners - is the stuff of informed business decisions.

​

​

Regulatory

 

 

 

 

 

 

 

​

​

​

 

 

Commercial     

​

FDARC provides practical, gold standard counsel on the FDCA and related health care laws - FTC, AKS, Stark, Sunshine Act, CPOM, HIPAA and licensing. We advise on course-of-business matters including product development, risk assessment and mitigation, registration and listing, approval and clearance, operations and cGMP, product claims, packaging and labeling, marketing, advertising and promotion with traditional and digital assets, supply chain, and FDA inspections. Should adverse events arise, we are adept at managing recalls, 483s, warning letters, and other enforcement actions. We help our clients develop strategies for handling legal issues in creative, business-centric ways and build processes that address risk and allow flexibility. We also continually monitor key evolving issues in regulation and industry practices to educate internal stakeholders and support external advocacy. 

FDARC provides cross-functional legal support where business and compliance meet. We are a resource for teams, specialists, management and leadership across verticals. Our strategic counsel extends from the day-to-day, such as commercial contracts with regulatory implications, to global matters of value maximization. To that end, we provide tailored strategies for organic growth including optimization of processes, allocation of resources, and product development, as well as those for inorganic growth through M&A and divestitures, including presentations, due diligence, negotiation, drafting and post-event integration. 

dots_edited.png

LITIGATION

FDA Regulatory Counsel handles, manages and supervises a wide range of domestic and international disputes involving regulated consumer products. We are barred in multiple jurisdictions nationally and experienced in all stages of litigation including initial strategy, motions practice, discovery and negotiations. We add insight on complex compliance issues by providing subject matter expertise. FDARC is also experienced in handling DOJ enforcement actions for FDA-regulated clients.

 

Representative Matters

​

  • Apply regulatory insight to global issues of fact and law in national MDL proceedings.

​

  • Negotiate resolution of individual plaintiff matters for consumer products clients.

​

  • Advise on and conduct compliance-related discovery, including drafting interrogatories, taking depositions, and interpreting information and documents.

​

  • Support expert witness testimony.

​

  • Inform motions practice and trial proceedings on FDA-related issues.

Conversation in Court
Government Building Columns
dots_edited.png

ADVOCACY & GOVERNMENT RELATIONS

FDA Regulatory Counsel's Washington, DC practice provides subject matter expertise to government relations teams. As regulatory lawyers, we are uniquely able to educate legislators and regulators on developing laws, regulations, public policy and enforcement guidelines.

​​

FDARC is particularly focused on innovative life sciences and emerging industries. We have counseled individual lawmakers and committees on the precedents and implications of new regulations, including:

 

  • Medical device 510(k) overhaul

  • Classification of innovative products

  • Dietary Supplement Health and Education Act (DSHEA)

  • 503B Compounding Pharmacy Act

  • DTC advertising & promotion in traditional and social media formats

  • Off-label claims and scientific exchange policies

  • Telehealth, digital health and medtech development

  • Food Safety Modernization Act (FSMA)

  • Tobacco Deeming Rule (e-cigarettes/vape)

  • Hemp, CBD and cannabis policy

​

Representative Matters

​

  • Liaise with government and regulatory bodies, including FDA, on regulated products, scientific information, formal and informal inquiries, and legislative and regulatory policies.

​

  • Draft comments and responses to regulatory dockets, proposed laws and regulations, FDA guidance documents, and industry group policy positions.

​

  • Inform and shape advocacy before Congress, FDA, and other federal and state bodies on existing and emerging legislation and policies.

FDA REGULATORY COUNSEL LLP

 

1717 K St., NW

Suite 900

Washington, DC 20006

​

202.714.0856 

linkedinsquarelogo.png
Peach Colorful Icon Abstract Logo (2).png

© 2025  by FDA Regulatory Counsel LLP

This site is not intended to be legal advice. Contacting the firm or reading the materials on the site does not create an attorney-client relationship. No confidential information should be sent over the internet. Past results do not predict future outcomes as each situation has to stand on its own. 

bottom of page